SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-030753
Filing Date
2023-03-09
Accepted
2023-03-09 21:32:44
Documents
1
Period of Report
2023-03-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm238905-10_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm238905-10_4seq1.xml 4 7559
  Complete submission text file 0001104659-23-030753.txt   9178
Mailing Address C/O INNOVIVE PHARMACEUTICALS, INC. 555 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
Kelly Steven (Reporting) CIK: 0001339478 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 23721454

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations